Evaluating Edge-to-edge Transcatheter Tricuspid Valve Repair in Patients With Severe Symptomatic Tricuspid Regurgitation
A trial with no phase registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 150 participants.
Also called NCT05628779
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 150 participants
- Sponsor
- Registry
-
NCT05628779
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Netherlands
- Registry status
- Enrolling by invitation
Technical summary
Registry record NCT05628779. Randomized; no masking; primary purpose treatment. Start 2022-12-12 (actual); primary completion 2027-11-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluating Edge-to-edge Transcatheter Tricuspid Valve Repair in Patients With Severe Symptomatic Tricuspid Regurgitation
- Acronym
- TRACE-NL
- Condition
- Tricuspid Valve Regurgitation, Nonrheumatic
- Condition
- Cardiac Catheterization
- Condition
- Heart Failure, Right Sided
- Condition
- Valve Regurgitation, Tricuspid
- Intervention (Device)
- TriClip TTVr system (Abbott Vascular)
- Intervention (Device)
- PASCAL TTVr system (Edwards Lifesciences)
- Lead sponsor
- St. Antonius Hospital
- Collaborator
- ZonMw: The Netherlands Organisation for Health Research and Development
Record details
- Record id
cardio:ct-nct05628779- Content hash
68cad7f8a2a53d5bd8498c8bc8f86d12606e650222529851327afd9ee0f469f9